Delivery Order SPE2DR25D1100-SPE2DR26FCL3D
- Not listed
- The Defense Logistics Agency awarded a $13,137.57 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract is set to conclude on October 27, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. As a non-set-aside procurement, the award reflects AmerisourceBergen's continued role as a critical pharmaceutical supplier within the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide injection) with an ultimate completion date of September 25, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections, with a ceiling value of $1,143.87 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $20,970.95. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,525.16 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by July 16, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply relationship with the Defense Logistics...
- The Defense Logistics Agency awarded a $4,868.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 ml pen injectors on September 11, 2025, with completion expected by September 12, 2025. This non-set-aside contract represents a single delivery order fulfillment for the diabetes and weight management medication, performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award reflects the company's role as a...
- The Defense Logistics Agency awarded a $17,465.56 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This firm fixed-price, competitively awarded contract is scheduled for completion by October 22, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,380.95 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract involves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens in 0.5 mL single-dose units, valued at $3,065.58. This competitive award represents a firm fixed price delivery order with an ultimate completion date of October 20, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL3DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, valued at $29,770.98, is a firm fixed-price delivery order with a completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.8k | 10/29/25 |